Invitation to QuickMIC® launch webinar
Gradientech is hosting a live webinar on the 29th of June 2022 at 14:00 (CEST). Current developments in next generation antibiotic susceptibility testing (AST) and state of the art performance with QuickMIC® will be presented.
QuickMIC® is a class-leading device providing reliable AST results in 2-4 hours and is the fastest system for growth-based testing of antibiotic susceptibility for sepsis patients. Join the webinar to learn about how Gradientech’s QuickMIC system holds promise to close a significant diagnostic gap and essentially improve patient care.
You will listen to three well renowned speakers who will share valuable insights into how we together can use and bring new innovations in rapid antibiotic susceptibility testing into clinical practice.
We will also discuss the importance of new technologies for microbiologists, the treating physicians, and the critically ill sepsis patients.
Time: 29th of June 2022 at 14:00 -15:00 (CEST)
Speakers:
Jeffrey M. Bender, MD
Associate Professor of Pediatrics | Pediatric Infectious Diseases | Medical Microbiology | Childrens Hospital Los Angeles, USA
Holger Rohde, MD
Medical Microbiologist | Prof. Molecular Microbiology | Institute for Medical Microbiology, Virology and Hygiene | University Medical Center Hamburg-Eppendorf, Germany
Christer Malmberg, PhD
Chief Scientist | Gradientech, Sweden
About Gradientech
Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics in infectious disease medicine. Our product QuickMIC allows patients with sepsis to quickly receive specific guidance on the right antibiotic in the right dose. It saves lives, reduces healthcare costs and limits the spread of antibiotic resistance – one of the greatest global health threats of our time. Gradientech is headquartered in Uppsala. Visit www.gradientech.se for more information.
